Cardiovascular diseases (CVD) are the leading cause of death worldwide, claiming over 18 million lives annually. The term ...

Backed into a corner of grim options and bounced between hospital departments, Mr Doherty chanced upon groundbreaking Nobel Prize-winning immunotherapy at the Chris O’Brien Lifehouse.

Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is ...

Dr. Beutler was awarded the 2011 Nobel Prize in Physiology or Medicine for ... same mice with a checkpoint inhibitor drug, a type of immunotherapy. On the other hand, without monoclonal antibodies ...

Programmed cell death protein 1,” or PD-1, has been considered a key target in cancer therapies since its discovery in the ...

On December 22, 2024, the "BioV Life Science and Regenerative Medicine International Summit," a significant event in the life ...

Jimmy Carter, the Georgia peanut farmer who became a U.S. president and a Nobel Prize-winning activist for peace and human rights, has died. He was 100.

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Jimmy Carter, 39th president of the United States, Nobel Peace Prize recipient ... and he underwent immunotherapy and radiation therapy. "I just thought I had a few weeks left, but I was ...

In 2002, Carter received the Nobel Peace Prize for what the awards committee ... including targeted radiation and immunotherapy, Carter announced in early December 2015 that a subsequent brain ...